PWM
BBOT

Palumbo Wealth Management’s BridgeBio Oncology BBOT Stock Holding History

Palumbo Wealth Management’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$652K Buy
+85,624
New +$715K 0.14% 115

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Palumbo Wealth Management's BBOT Position: Q2 2026 in Review

Palumbo Wealth Management opened a new position in BridgeBio Oncology (BBOT) in Q2 2026: 85,624 shares worth $652K. The stake represents 0.14% of the portfolio and ranks #115 among its holdings.

66 funds tracked by Wall St. Rank hold BBOT as of Q2 2026.

  • Palumbo Wealth Management held 85,624 shares of BridgeBio Oncology worth $652K as of Q2 2026.
  • BridgeBio Oncology was a new Palumbo Wealth Management position in Q2 2026.
  • BridgeBio Oncology made up 0.14% of Palumbo Wealth Management's portfolio in Q2 2026, its #115 holding.
  • 66 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.